Psychometric parameters of the subscale of hostility from the Symptom Checklist 90 (SCL-90)

Cavalcanti, Jaqueline Gomes; Moura, Giovanna Barroca de; Pimentel, Carlos Eduardo

doi:10.1590/1413-82712019240213

Cited by 5 publications

(7 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We did not study a distinct diagnostic group, but the de ned symptom clusters in SCL-90 across diagnostic groups. In general, the cluster anger hostility in SCL-90 provide evidence of satisfactory validity and reliability [42,43]. Anger refers to emotional state encompassing feelings ranging from mild annoyance to intense fury and anger, accompanied by autonomic nervous system stimulation.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Transdiagnostic associations between anger hostility and chemokine interferon-gamma inducible protein 10 (CXCL 10)

Soloey-Nilsen

Nygaard-Odeh

Kristiansen

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Many psychiatric disorders are linked to low grade systemic inflammation as measured by systemic cytokine levels. Exploration of cytokines and immune activity and their role in psychiatric symptoms may inform pathobiology and treatment opportunities. Methods This was a cross sectional naturalistic study with 132 participants from a general open inpatient psychiatric ward at the Nordland Hospital Trust, Norway. Serum levels of 28 different cytokines were assessed. Psychiatric symptoms the last week were assessed by a self-rating scale (Symptom check list, SCL-90- R) and grouped in defined clusters. Multiple linear regression model was used for statistical analyses of associations between levels of cytokines and symptoms, adjusting for possible confounding factors. Results We found a positive association (p0.009) between the chemokine interferon-gamma inducible protein 10 (CXCL 10; IP-10) and the anger hostility cluster. No associations were found between the other symptom clusters and cytokines. IP-10 and the anger hostility cluster were positively associated (p 0.002) in the subgroup of patients using psychotropic medication, not in the subgroup not using psychotropic medication. Conclusion Our analyses revealed a significant positive association between the symptom cluster anger hostility in SCL-90-R and the chemokine IP-10 in the subgroup of patients using psychotropic medications.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Hostility is constituted as a belief, expectation and negative attitudes toward persons and things. Anger hostility appears to be a risk factor for health and psychological wellbeing [42].…”

Section: Discussionmentioning

confidence: 99%

Transdiagnostic associations between anger hostility and chemokine interferon-gamma inducible protein 10 (CXCL 10)

Soloey-Nilsen

Nygaard-Odeh

Kristiansen

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…We did not study a distinct diagnostic group, but the defined symptom clusters in SCL-90 across diagnostic groups. In general, the cluster anger hostility in SCL-90 provide evidence of satisfactory validity and reliability [ 44 , 45 ]. Anger refers to emotional state encompassing feelings ranging from mild annoyance to intense fury and anger, accompanied by autonomic nervous system stimulation.…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Transdiagnostic Associations between Anger Hostility and Chemokine Interferon-gamma Inducible Protein 10

Soloey-Nilsen

Nygaard-Odeh

Kristiansen

et al. 2023

Clin Psychopharmacol Neurosci

View full text Add to dashboard Cite

Objective Many psychiatric disorders are linked to low grade systemic inflammation as measured by systemic cytokine levels. Exploration of cytokines and immune activity and their role in psychiatric symptoms may inform pathobiology and treatment opportunities. The aim of this study is to explore if there are associations between cytokines and psychiatric symptom clusters. Comparison between patients regularly using and those not using psychotropic medication is also conducted. Methods This was a cross sectional naturalistic study with 132 participants from a general open inpatient psychiatric ward at the Nordland Hospital Trust, Norway. Serum levels of 28 different cytokines were assessed. Psychiatric symptoms the last week were assessed by a self-rating scale (Symptom check list, SCL-90-R) and grouped in defined clusters. Multiple linear regression model was used for statistical analyses of associations between levels of cytokines and symptoms, adjusting for possible confounding factors. Results We found a positive association ( p = 0.009) between the chemokine interferon-gamma inducible protein 10 (CXCL 10; IP-10) and the anger hostility cluster. No associations were found between the other symptom clusters and cytokines. IP-10 and the anger hostility cluster were positively associated ( p = 0.002) in the subgroup of patients using psychotropic medication, not in the subgroup not using psychotropic medication. Conclusion Our analyses revealed a significant positive association between the symptom cluster anger hostility in SCL-90-R and the chemokine IP-10 in the subgroup of patients using psychotropic medications.

show abstract

“…The Hostility subscale of the SCL-90-R contains six 5-point Likert scale items ranging from 0 (not at all) to 4 (extremely) and assesses anger related thoughts, feelings, and actions. The subscale demonstrated satisfactory validity and reliability [ 73 , 74 ].…”

Section: Methodsmentioning

confidence: 99%

The effect of twice-weekly versus once-weekly sessions of either imagery rescripting or eye movement desensitization and reprocessing for adults with PTSD from childhood trauma (IREM-Freq): a study protocol for an international randomized clinical trial

Wibbelink

Lee

Bachrach

et al. 2021

Trials

View full text Add to dashboard Cite

Background Trauma-focused treatments for posttraumatic stress disorder (PTSD) are commonly delivered either once or twice a week. Initial evidence suggests that session frequency affects treatment response, but very few trials have investigated the effect of session frequency. The present study’s aim is to compare treatment outcomes of twice-weekly versus once-weekly sessions of two treatments for PTSD related to childhood trauma, imagery rescripting (ImRs) and eye movement desensitization and reprocessing (EMDR). We hypothesize that both treatments will be more effective when delivered twice than once a week. How session frequency impacts treatment response, whether treatment type moderates the frequency effect, and which treatment type and frequency works best for whom will also be investigated. Methods The IREM-Freq trial is an international multicenter randomized clinical trial conducted in mental healthcare centers across Australia, Germany, and the Netherlands. We aim to recruit 220 participants, who will be randomized to one of four conditions: (1) EMDR once a week, (2) EMDR twice a week, (3) ImRs once a week, or (4) ImRs twice a week. Treatment consists of 12 sessions. Data are collected at baseline until one-year follow-up. The primary outcome measure is clinician-rated PTSD symptom severity. Secondary outcome measures include self-reported PTSD symptom severity, complex PTSD symptoms, trauma-related cognitions and emotions, depressive symptoms, dissociation, quality of life, and functioning. Process measures include memory, learning, therapeutic alliance, motivation, reluctance, and avoidance. Additional investigations will focus on predictors of treatment outcome and PTSD severity, change mechanisms of EMDR and ImRs, the role of emotions, cognitions, and memory, the optimization of treatment selection, learned helplessness, perspectives of patients and therapists, the network structure of PTSD symptoms, and sudden treatment gains. Discussion This study will extend our knowledge on trauma-focused treatments for PTSD related to childhood trauma and, more specifically, the importance of session frequency. More insight into the optimal session frequency could lead to improved treatment outcomes and less dropout, and in turn, to a reduction of healthcare costs. Moreover, the additional investigations will broaden our understanding of how the treatments work and variables that affect treatment outcome. Trial registration Netherlands Trial Register NL6965, registered 25/04/2018.

show abstract

Psychometric parameters of the subscale of hostility from the Symptom Checklist 90 (SCL-90)

Cited by 5 publications

References 32 publications

Transdiagnostic associations between anger hostility and chemokine interferon-gamma inducible protein 10 (CXCL 10)

Transdiagnostic associations between anger hostility and chemokine interferon-gamma inducible protein 10 (CXCL 10)

Transdiagnostic Associations between Anger Hostility and Chemokine Interferon-gamma Inducible Protein 10

The effect of twice-weekly versus once-weekly sessions of either imagery rescripting or eye movement desensitization and reprocessing for adults with PTSD from childhood trauma (IREM-Freq): a study protocol for an international randomized clinical trial

Contact Info

Product

Resources

About